TherapeuticsMD(TXMD) - 2020 Q4 - Annual Report
TherapeuticsMD(TXMD)2021-03-04 00:48UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ________________________ Commission File Number 001-00100 TherapeuticsMD, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other ...